1FW2

WUXI BIOLOGICS-00000083

Healthcare · EUR · F

1FW2

Price

€3.522

-2.36%

Cap

€14.96B

Earnings

30d Trend

-6.8%

1FW2
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

45% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level58
Quality69
Momentum73
Technical42
Fundamentals85

Raw weighted: 67×Macro 0.99 (1%)=66

RISK

58/100
90d Volatility
44.6%High
ATR %
2.6%Normal
Max Drawdown (1Y)
-26.9%Normal

QUALITY

69/100
ROE (avg)
11.6%Good
Piotroski F-Score
7/9Strong
Margin Stability
CV 6.9%Stable
Accruals
-2.2%Cash earnings
Interest Coverage
49.3xVery comfortable

MOMENTUM

73/100
12-1M Momentum
+24.0%Strong uptrend
6-1M Momentum
+5.5%Positive
1M Return
-2.4%Stable

TECHNICAL

42/100
RSI (14)
43.7Neutral
Price vs SMA200
-8.8%Bearish trend
MACD
0.00Bearish momentum
Bollinger Band
24%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.092Noisy/choppy

FUNDAMENTALS

85/100
EV/EBIT
0.8Cheap
P/FCF
5.7Cheap
P/S
0.7Cheap
PEG
1.05Fair growth
Shareholder Yield
10.5%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44
3-12 months41
1-5+ years74

Long-term compounder with 10.5% yield

BRAIN47'S ASSESSMENT

I rate WUXI BIOLOGICS-00000083 at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 85/100. I classify this as a income position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-2.4%

3 MONTHS

-17.7%

12 MONTHS

+21.6%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder with 10.5% yield. Fundamentals (85) and Momentum (73) are the primary strengths. I note that technical is the weakest area at 42/100 — this warrants monitoring. Historical volatility is elevated at 45%. I classify this as an income position — the 10.5% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 66/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.